Protocols
ADP-0000-001-SCR Phase N/A OPEN TO ACCRUAL
A Screening Protocol to Determine Tumor Antigen Expression and HLA Sub-Type for Eligibility Determination for Clinical Trials Evaluating the Safety and Efficacy of Autologous T Cells Expressing Enhanced TCRs in Subjects with Solid or Hematological Malignancies
ALLIANCE-A222004-ANOREXIA Phase III OPEN TO ACCRUAL
A Randomized Phase III Trial of Olanzapine Versus Megestrol Acetate for Cancer-Associated Anorexia
GSK-3377794-LTFU Phase N/A OPEN TO ACCRUAL
Long Term Follow-Up of Participants Exposed to GSK3377794 (NY- ESO-1c259 T), a Genetically Engineered NY-ESO-1 Specific T Cell Receptor